Shandong Drug Patent Portfolio
Shandong owns 1 orange book drug protected by 5 US patents Given below is the list of Shandong's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10098882 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
| US10406161 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
| US11110094 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
| US9446135 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
| US9532991 | Risperidone sustained release microsphere composition | 10 Apr, 2032 | Active |
Latest Legal Activities on Shandong's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Shandong.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 06 Mar, 2025 | US11110094 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 03 Jul, 2024 | US9532991 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 19 Mar, 2024 | US9446135 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Mar, 2023 | US10406161 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 28 Mar, 2022 | US10098882 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Sep, 2021 | US11110094 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Sep, 2021 | US11110094 |
|
Email Notification
Critical
| 19 Aug, 2021 | US11110094 |
|
Issue Notification Mailed
Critical
| 18 Aug, 2021 | US11110094 |
|
Application Is Considered Ready for Issue
Critical
| 05 Aug, 2021 | US11110094 |
| Dispatch to FDC | 05 Aug, 2021 | US11110094 |
|
Issue Fee Payment Received
Critical
| 04 Aug, 2021 | US11110094 |
|
Issue Fee Payment Verified
Critical
| 04 Aug, 2021 | US11110094 |
|
Electronic Review
Critical
| 05 May, 2021 | US11110094 |
|
Email Notification
Critical
| 05 May, 2021 | US11110094 |
Shandong Drug Patents' Oppositions Filed in EPO
Shandong drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jun 20, 2017, by Lecomte & Partners. This opposition was filed on patent number EP12777430A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP19176691A | Jul, 2021 | Alkermes Pharma Ireland Limited | Opposition rejected |
| EP16179390A | Apr, 2020 | Alkermes Pharma Ireland Limited | Opposition rejected |
| EP16179390A | Apr, 2020 | Aera A/S | Opposition rejected |
| EP12777430A | Jun, 2017 | Lecomte & Partners | Opposition rejected |
Shandong's Family Patents
Recent FDA approvals and tentative approvals for Shandong
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Brivaracetam |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 26 Feb, 2026 |
Clinical Trials
Recent Clinical Trials by Shandong:
Shandong Drug List
Given below is the complete list of Shandong's drugs and the patents protecting them.
1. Rykindo
Rykindo is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10098882 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(5 years from now)
| Active |
| US10406161 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(5 years from now)
| Active |
| US11110094 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(5 years from now)
| Active |
| US9446135 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(5 years from now)
| Active |
| US9532991 | Risperidone sustained release microsphere composition |
10 Apr, 2032
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rykindo's drug page